N-Acetylcysteine Reduced Acute Mouse Activity, but Sensitization Was a Separate Result
A drug can reduce an immediate behavioral response without demonstrating that it prevents the development of sensitization. Máchalová and colleagues tested N-acetylcysteine, or NAC, alongside methamphetamine in mice. Their results require keeping those two comparisons separate.
Eight groups followed different treatment sequences
The experiment began with 104 mice randomly divided into eight groups of 13. The investigators used saline, NAC, methamphetamine or their combination during an initial daily treatment period. All groups then received methamphetamine challenges, with further treatment sequences and later challenges used to examine how responses developed over time.
The reported NAC and methamphetamine doses were 50 and 2.5 mg/kg respectively, administered intraperitoneally. These are conditions of an animal experiment. They do not establish a human dose or demonstrate the effect of an orally administered supplement.
The acute locomotor comparison was statistically significant
After the acute dose, the combination group moved less than the methamphetamine-only group in the open-field test; the paper reports p = 0.011 for that comparison. Both groups nevertheless showed greater locomotor activity than the saline and NAC-only conditions.
Thus, reduced stimulation relative to methamphetamine alone did not mean no stimulation. The comparator determines what the result can support.
The sensitization conclusion was more limited
The authors described a nonsignificant trend toward attenuated development of behavioral sensitization with simultaneous long-term administration. That wording should remain intact. A significant acute effect cannot be substituted for a statistically established difference in the development of sensitization.
Locomotor sensitization also differs from drug seeking, self-administration, clinical dependence and relapse. Measuring how far a mouse moves after a challenge does not directly measure whether a person stops using methamphetamine.
What remains untested
This paper did not conduct a human treatment trial or assess driving, occupational performance or an individual patient’s recovery. NAC’s other uses do not supply evidence for those unmeasured outcomes in this experiment.
The study contributes evidence about an acute locomotor interaction and a more uncertain repeated-exposure pattern. Preserving that distinction supports further research without turning a preliminary animal finding into a demonstrated human addiction treatment.
Scientific source
Máchalová A, Landa L, Máchal J, Demlová R, Slíva J. The Effect of N-Acetylcysteine on Behavioral Sensitization to Methamphetamine in Mice. Physiological Research (2025), 74:337–346. DOI: 10.33549/physiolres.935471. Original explanation of the supplied paper.



